Hoffmann C, Moro S, Nicholas R A, Harden T K, Jacobson K A
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Biol Chem. 1999 May 21;274(21):14639-47. doi: 10.1074/jbc.274.21.14639.
The P2Y1 receptor is a membrane-bound G protein-coupled receptor stimulated by adenine nucleotides. Using alanine scanning mutagenesis, the role in receptor activation of charged amino acids (Asp, Glu, Lys, and Arg) and cysteines in the extracellular loops (EL) of the human P2Y1 receptor has been investigated. The mutant receptors were expressed in COS-7 cells and measured for stimulation of phospholipase C induced by the potent agonist 2-methylthioadenosine-5'-diphosphate (2-MeSADP). In addition to single point mutations, all receptors carried the hemagglutinin epitope at the N- terminus for detection of cell-surface expression. The C124A and C202A mutations, located near the exofacial end of transmembrane helix 3 and in EL2, respectively, ablated phospholipase C stimulation by </=100 microM 2-MeSADP. Surface enzyme-linked immunosorbent assay detection of both mutant receptors showed <10% expression, suggesting that a critical disulfide bridge between EL2 and the upper part of transmembrane 3, as found in many other G protein-coupled receptors, is required for proper trafficking of the P2Y1 receptor to the cell surface. In contrast, the C42A and C296A mutant receptors (located in the N-terminal domain and EL3) were activated by 2-MeSADP, but the EC50 values were >1000-fold greater than for the wild-type receptor. The double mutant receptor C42A/C296A exhibited no additive shift in the concentration-response curve for 2-MeSADP. These data suggest that Cys42 and Cys296 form another disulfide bridge in the extracellular region, which is critical for activation. Replacement of charged amino acids produced only minor changes in receptor activation, with two remarkable exceptions. The E209A mutant receptor (EL2) exhibited a >1000-fold shift in EC50. However, if Glu209 were substituted with amino acids capable of hydrogen bonding (Asp, Gln, or Arg), the mutant receptors responded like the wild-type receptor. Arg287 in EL3 was impaired similarly to Glu209 when substituted by alanine. Substitution of Arg287 by lysine, another positively charged residue, failed to fully restore wild-type activity.
P2Y1受体是一种受腺嘌呤核苷酸刺激的膜结合型G蛋白偶联受体。利用丙氨酸扫描诱变技术,研究了人P2Y1受体胞外环(EL)中带电荷氨基酸(天冬氨酸、谷氨酸、赖氨酸和精氨酸)及半胱氨酸在受体激活中的作用。将突变受体在COS-7细胞中表达,并检测强效激动剂2-甲硫腺苷-5'-二磷酸(2-MeSADP)诱导的磷脂酶C激活情况。除单点突变外,所有受体在N端均带有血凝素表位,用于检测细胞表面表达。分别位于跨膜螺旋3外表面末端附近和EL2中的C124A和C202A突变,使浓度≤100μM的2-MeSADP诱导的磷脂酶C激活作用消除。对两种突变受体进行表面酶联免疫吸附测定,结果显示表达量<10%,这表明P2Y1受体向细胞表面的正常转运需要EL2与跨膜3上部之间形成一个关键的二硫键,正如在许多其他G蛋白偶联受体中所发现的那样。相反,C42A和C296A突变受体(分别位于N端结构域和EL3)可被2-MeSADP激活,但其半数有效浓度(EC50)值比野生型受体高>1000倍。双突变受体C42A/C296A对2-MeSADP的浓度-反应曲线未出现叠加性偏移。这些数据表明,半胱氨酸42和半胱氨酸296在细胞外区域形成了另一个对激活至关重要的二硫键。带电荷氨基酸的替换仅使受体激活产生微小变化,但有两个显著例外。E209A突变受体(EL2)的EC50值出现>1000倍的偏移。然而,如果将谷氨酸209替换为能够形成氢键的氨基酸(天冬氨酸、谷氨酰胺或精氨酸),则突变受体的反应与野生型受体相似。EL3中的精氨酸287被丙氨酸替换时,其功能受损情况与谷氨酸209类似。用另一个带正电荷的残基赖氨酸替换精氨酸287未能完全恢复野生型活性。